The FY2025 (Dec) proxy of ADC Therapeutics SA names 20 peer companies for pay. Pay versus performance data of ADC Therapeutics SA for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| 2seventy bio, Inc. (acquired by Bristol Myers Squibb) | Not disclosed | Not disclosed |
| Adaptimmune Therapeutics plc | Not disclosed | Not disclosed |
| Akebia Therapeutics, Inc. [AKBA] | Not disclosed | Not disclosed |
| Allogene Therapeutics, Inc. [ALLO] | Not disclosed | Not disclosed |
| Aquestive Therapeutics, Inc. [AQST] | Not disclosed | Not disclosed |
| Esperion Therapeutics, Inc. [ESPR] | Not disclosed | Not disclosed |
| Fate Therapeutics, Inc. [FATE] | Not disclosed | Not disclosed |
| Heron Therapeutics [HRTX] | Not disclosed | Not disclosed |
| Immunome, Inc. [IMNM] | Not disclosed | Not disclosed |
| KaryoPharm Therapeutics Inc. [KPTI] | Not disclosed | Not disclosed |
| MacroGenics [MGNX] | Not disclosed | Not disclosed |
| Mersana Therapeutics, Inc. (acquired by Day One Biopharmaceuticals) | Not disclosed | Not disclosed |
| Nektar Therapeutics [NKTR] | Not disclosed | Not disclosed |
| Puma Biotechnology, Inc. [PBYI] | Not disclosed | Not disclosed |
| Pyxis Oncology, Inc. [PYXS] | Not disclosed | Not disclosed |
| Rigel Pharmaceuticals [RIGL] | Not disclosed | Not disclosed |
| Urogen Pharma Ltd. [URGN] | Not disclosed | Not disclosed |
| X4 Pharmaceuticals [XFOR] | Not disclosed | Not disclosed |
| Y-mAbs Therapeutics (acquired by SERB Pharmaceuticals) | Not disclosed | Not disclosed |
| Zymeworks Inc. [ZYME] | Not disclosed | Not disclosed |
20 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.